Trejo SÓA, Rodríguez AE, Tamariz HE, Casco MR, Díaz OE, López MMC

Language: Spanish
References: 10
Page: 7-10
PDF size: 55.40 Kb.

ABSTRACT

Introduction: The Pap smear remains an effective, widely used method for early detection of pre and cervical cancer. Since its introduction, and with the screening programs, the prevalence of cervical cancer has diminished to 70% in developed countries. This study evaluate the efficacy in the detection of cells, we compared the polyethylene brush (Group «B») with the Ayre spatula and Cytobrush (Group «C»). Results: We found a greater proportion of endocervical, exocervical and mixed cells in Group «B» (p ‹ 0.05). According to the Bethesda System, we found that AUSCUS, AGC and LSGIL were diagnosed more frequently in Group «B» (p ‹ 0.05), with a relative risk of 4.32, 6.17 and 1.53. Invasive cancer resulted to be diagnosed more often in Group «C» (p ‹ 0.05). Discussion: Early detection and prevention of cervix cancer is essential in Health Programs. It is well known that since the evidence published by the Cochrane Reviewers in Gynecologic cancer in 2002, the recollection of cells has not been proven to be so effective in cell recollection when the Ayre Spatula is used. Our study supports this evidence because the polyethylene brush resulted more effective with a considerable relative risk.

REFERENCES

1. Organización Mundial de la Salud; Manual del control integral del cáncer cervicouterino: Guía de prácticas esenciales. 2007: 3-4.

2. Organización Mundial de la Salud. Manual human papilloma virus and cancer cervical. 2007: 1-10.

3. Gutiérrez-Delgado C, Báez-Mendoza C, González-Pier E, Prieto-De la Rosa A, Witlen R. Relación costo-efectividad de las intervenciones preventivas contra el cáncer cervical en mujeres mexicanas. Salud Pública Mex 2008; 50: 107-118.

4. National Center Institute. Surveillance epidemiology and end results (SEER).http://seer.cancer.org

5. Lazcano PE, Moss S, Cruz VA, Alonso de Ruiz P, Casares QS, Martínez LC et al. Factores que determinan la participación en el tamizaje de cáncer cervical en el estado de Morelos. Salud Pública Mex 1999; 41: 278-85.

6. Chang A. The cervical smear test in the next millennium. HKMJ 1999; 5: 294-302

7. Centro para el Control y Prevención de Enfermedades (CDC). Manual informativo: Virus de papiloma humano. Agosto de 2007.

8. Bosch FX, San José S, Castellsague X. Understanding the origin of cervical cancer. HPV Handbook. Taylor & Francis. 2004: 42-54.

9. Bergeron Ch. The 2001 Bethesda system. Revista de Salud Pública de México. S340-S344. 2003.

10. Martin-Hirsch P, Jarvis G, Kitchener H, Lilford R. Dispositivos de recolección de muestras citológicas cervicales (Cochrane Review). In: La Biblioteca Cochrane Plus, Issue 3, 2008. Oxford: Update Software.